This site is intended for health professionals only
Tuesday 21 November 2017

Top stories

17.11.17: Robust analytical, pharmacological, non–clinical and clinical data demonstrated the similarity of Cyltezo® to Humira®
17.11.17: Within the framework of the Innovative Medicines Initiative, EFPIA, EBE and Vaccines Europe are also supporting an extensive...
17.11.17: Trelegy Ellipta is the first once-daily single inhaler triple therapy to be approved in Europe
02.11.17: Trace is the first data visualisation and reporting software compatible with the full capabilities of the Masimo Root Patient...
09.11.17: NICE also recommends use of Merck’s multiple sclerosis therapy cladribine (Mavenclad®) for highly active disease in adults
02.11.17: Patients with ‘forgotten cancer’ to access new immunotherapy Tecentriq® (atezolizumab) via Cancer Drugs Fund

Extra news

It is estimated that up to 5000-6000 nurses and 2000-3000 doctors use point of care testing equipment 24 hours a day
Mark Cusworth examines EU Medical Device Regulation and its implications on labelling – and looks ahead to a Christmas future that could become a nightmare unless...
An ambitious project to link the Orion Health portals in use at five West of Scotland health boards has just been completed; and is already delivering significant...


HHE supplements are created to provide readers with dedicated resources and materials for specific areas of healthcare. Click on the images below to access the latest supplements.

2017 eBook